Methotrexate and misoprostol vs misoprostol alone for early abortion: A randomized controlled trial

Mitchell D Creinin, Eric Vittinghoff

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

Objective. - To compare the safety and efficacy of early abortion by administration of methotrexate and misoprostol vs administration of misoprostol alone. Design. - Randomized controlled trial. Setting. - San Francisco (Calif) General Hospital. Patients. - Pregnant women at 56 days' gestation or less seeking elective abortion. Sixty-three women volunteered for the trial; 61 completed the study and are included in the analysis. Intervention. - Intramuscular administration of 50 mg of methotrexate per square meter of body surface area followed 3 days later by vaginal administration of 800 μg of misoprostol (group 1) or the same dose of misoprostol given alone (group 2). The misoprostol dose was repeated 24 hours later if abortion had not occurred. Main Outcome Measures. - Successful abortion, duration of vaginal bleeding, side effects, and change in β-human chorionic gonadotropin (β-hCG) level. An abortion was considered successful if the pregnancy ended without requiring a surgical procedure. Results. - Complete abortion occurred in 28 (90%) of 31 patients in group 1 and 14 (47%) of 30 patients in group 2 (P<.001). Seventeen (61%) of the 28 women in group 1 who aborted did so the same day as misoprostol administration; vaginal bleeding lasted a mean (±SD) of 10 (±4) days, and β-hCG level was less than or equal to 10 IU/L by a mean of 31 (±6) days after methotrexate administration. The 11 other women in group 1 who aborted did so after a mean delay of 29 (±11) days; vaginal bleeding lasted 7 (±4) days, and β-hCG level was less than or equal to 10 IU/L by a mean of 24 (±11) days after the abortion. There were three treatment failures in group 1: two ongoing pregnancies (6%) and one incomplete abortion (3%). For the 14 women with successful abortions in group 2, vaginal bleeding lasted a mean of 10 (±6) days and β-hCG level was less than or equal to 10 IU/L by a mean of 39 (±18) days after the misoprostol. There were 16 treatment failures in group 2: eight ongoing pregnancies (27%), and eight incomplete abortions (27%). Methotrexate side effects were minimal. Misoprostol side effects were diarrhea in 18% and nausea and vomiting in 5%. Conclusions. - Methotrexate and vaginal misoprostol are more effective than misoprostol alone. Both drugs are available throughout the United States, and both drugs are inexpensive. This combination may offer an alternative to the use of antiprogestin and prostaglandin for medical abortion.

Original languageEnglish (US)
Pages (from-to)1190-1195
Number of pages6
JournalJournal of the American Medical Association
Volume272
Issue number15
DOIs
StatePublished - Oct 19 1994

Fingerprint

Misoprostol
Methotrexate
Randomized Controlled Trials
Uterine Hemorrhage
Incomplete Abortion
Pregnancy
Treatment Failure
Intravaginal Administration
San Francisco
Body Surface Area
Chorionic Gonadotropin
General Hospitals
Pharmaceutical Preparations
Nausea
Prostaglandins
Vomiting
Pregnant Women
Diarrhea
Outcome Assessment (Health Care)
Safety

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Methotrexate and misoprostol vs misoprostol alone for early abortion : A randomized controlled trial. / Creinin, Mitchell D; Vittinghoff, Eric.

In: Journal of the American Medical Association, Vol. 272, No. 15, 19.10.1994, p. 1190-1195.

Research output: Contribution to journalArticle

@article{639cb56f91ff4389975db9fcac8db0af,
title = "Methotrexate and misoprostol vs misoprostol alone for early abortion: A randomized controlled trial",
abstract = "Objective. - To compare the safety and efficacy of early abortion by administration of methotrexate and misoprostol vs administration of misoprostol alone. Design. - Randomized controlled trial. Setting. - San Francisco (Calif) General Hospital. Patients. - Pregnant women at 56 days' gestation or less seeking elective abortion. Sixty-three women volunteered for the trial; 61 completed the study and are included in the analysis. Intervention. - Intramuscular administration of 50 mg of methotrexate per square meter of body surface area followed 3 days later by vaginal administration of 800 μg of misoprostol (group 1) or the same dose of misoprostol given alone (group 2). The misoprostol dose was repeated 24 hours later if abortion had not occurred. Main Outcome Measures. - Successful abortion, duration of vaginal bleeding, side effects, and change in β-human chorionic gonadotropin (β-hCG) level. An abortion was considered successful if the pregnancy ended without requiring a surgical procedure. Results. - Complete abortion occurred in 28 (90{\%}) of 31 patients in group 1 and 14 (47{\%}) of 30 patients in group 2 (P<.001). Seventeen (61{\%}) of the 28 women in group 1 who aborted did so the same day as misoprostol administration; vaginal bleeding lasted a mean (±SD) of 10 (±4) days, and β-hCG level was less than or equal to 10 IU/L by a mean of 31 (±6) days after methotrexate administration. The 11 other women in group 1 who aborted did so after a mean delay of 29 (±11) days; vaginal bleeding lasted 7 (±4) days, and β-hCG level was less than or equal to 10 IU/L by a mean of 24 (±11) days after the abortion. There were three treatment failures in group 1: two ongoing pregnancies (6{\%}) and one incomplete abortion (3{\%}). For the 14 women with successful abortions in group 2, vaginal bleeding lasted a mean of 10 (±6) days and β-hCG level was less than or equal to 10 IU/L by a mean of 39 (±18) days after the misoprostol. There were 16 treatment failures in group 2: eight ongoing pregnancies (27{\%}), and eight incomplete abortions (27{\%}). Methotrexate side effects were minimal. Misoprostol side effects were diarrhea in 18{\%} and nausea and vomiting in 5{\%}. Conclusions. - Methotrexate and vaginal misoprostol are more effective than misoprostol alone. Both drugs are available throughout the United States, and both drugs are inexpensive. This combination may offer an alternative to the use of antiprogestin and prostaglandin for medical abortion.",
author = "Creinin, {Mitchell D} and Eric Vittinghoff",
year = "1994",
month = "10",
day = "19",
doi = "10.1001/jama.272.15.1190",
language = "English (US)",
volume = "272",
pages = "1190--1195",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "15",

}

TY - JOUR

T1 - Methotrexate and misoprostol vs misoprostol alone for early abortion

T2 - A randomized controlled trial

AU - Creinin, Mitchell D

AU - Vittinghoff, Eric

PY - 1994/10/19

Y1 - 1994/10/19

N2 - Objective. - To compare the safety and efficacy of early abortion by administration of methotrexate and misoprostol vs administration of misoprostol alone. Design. - Randomized controlled trial. Setting. - San Francisco (Calif) General Hospital. Patients. - Pregnant women at 56 days' gestation or less seeking elective abortion. Sixty-three women volunteered for the trial; 61 completed the study and are included in the analysis. Intervention. - Intramuscular administration of 50 mg of methotrexate per square meter of body surface area followed 3 days later by vaginal administration of 800 μg of misoprostol (group 1) or the same dose of misoprostol given alone (group 2). The misoprostol dose was repeated 24 hours later if abortion had not occurred. Main Outcome Measures. - Successful abortion, duration of vaginal bleeding, side effects, and change in β-human chorionic gonadotropin (β-hCG) level. An abortion was considered successful if the pregnancy ended without requiring a surgical procedure. Results. - Complete abortion occurred in 28 (90%) of 31 patients in group 1 and 14 (47%) of 30 patients in group 2 (P<.001). Seventeen (61%) of the 28 women in group 1 who aborted did so the same day as misoprostol administration; vaginal bleeding lasted a mean (±SD) of 10 (±4) days, and β-hCG level was less than or equal to 10 IU/L by a mean of 31 (±6) days after methotrexate administration. The 11 other women in group 1 who aborted did so after a mean delay of 29 (±11) days; vaginal bleeding lasted 7 (±4) days, and β-hCG level was less than or equal to 10 IU/L by a mean of 24 (±11) days after the abortion. There were three treatment failures in group 1: two ongoing pregnancies (6%) and one incomplete abortion (3%). For the 14 women with successful abortions in group 2, vaginal bleeding lasted a mean of 10 (±6) days and β-hCG level was less than or equal to 10 IU/L by a mean of 39 (±18) days after the misoprostol. There were 16 treatment failures in group 2: eight ongoing pregnancies (27%), and eight incomplete abortions (27%). Methotrexate side effects were minimal. Misoprostol side effects were diarrhea in 18% and nausea and vomiting in 5%. Conclusions. - Methotrexate and vaginal misoprostol are more effective than misoprostol alone. Both drugs are available throughout the United States, and both drugs are inexpensive. This combination may offer an alternative to the use of antiprogestin and prostaglandin for medical abortion.

AB - Objective. - To compare the safety and efficacy of early abortion by administration of methotrexate and misoprostol vs administration of misoprostol alone. Design. - Randomized controlled trial. Setting. - San Francisco (Calif) General Hospital. Patients. - Pregnant women at 56 days' gestation or less seeking elective abortion. Sixty-three women volunteered for the trial; 61 completed the study and are included in the analysis. Intervention. - Intramuscular administration of 50 mg of methotrexate per square meter of body surface area followed 3 days later by vaginal administration of 800 μg of misoprostol (group 1) or the same dose of misoprostol given alone (group 2). The misoprostol dose was repeated 24 hours later if abortion had not occurred. Main Outcome Measures. - Successful abortion, duration of vaginal bleeding, side effects, and change in β-human chorionic gonadotropin (β-hCG) level. An abortion was considered successful if the pregnancy ended without requiring a surgical procedure. Results. - Complete abortion occurred in 28 (90%) of 31 patients in group 1 and 14 (47%) of 30 patients in group 2 (P<.001). Seventeen (61%) of the 28 women in group 1 who aborted did so the same day as misoprostol administration; vaginal bleeding lasted a mean (±SD) of 10 (±4) days, and β-hCG level was less than or equal to 10 IU/L by a mean of 31 (±6) days after methotrexate administration. The 11 other women in group 1 who aborted did so after a mean delay of 29 (±11) days; vaginal bleeding lasted 7 (±4) days, and β-hCG level was less than or equal to 10 IU/L by a mean of 24 (±11) days after the abortion. There were three treatment failures in group 1: two ongoing pregnancies (6%) and one incomplete abortion (3%). For the 14 women with successful abortions in group 2, vaginal bleeding lasted a mean of 10 (±6) days and β-hCG level was less than or equal to 10 IU/L by a mean of 39 (±18) days after the misoprostol. There were 16 treatment failures in group 2: eight ongoing pregnancies (27%), and eight incomplete abortions (27%). Methotrexate side effects were minimal. Misoprostol side effects were diarrhea in 18% and nausea and vomiting in 5%. Conclusions. - Methotrexate and vaginal misoprostol are more effective than misoprostol alone. Both drugs are available throughout the United States, and both drugs are inexpensive. This combination may offer an alternative to the use of antiprogestin and prostaglandin for medical abortion.

UR - http://www.scopus.com/inward/record.url?scp=0027981098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027981098&partnerID=8YFLogxK

U2 - 10.1001/jama.272.15.1190

DO - 10.1001/jama.272.15.1190

M3 - Article

C2 - 7523739

AN - SCOPUS:0027981098

VL - 272

SP - 1190

EP - 1195

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 15

ER -